NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 73 filers reported holding NEOS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $651,000 | -65.4% | 950,311 | -62.1% | 0.06% | -74.0% |
| Q1 2020 | $1,882,000 | -64.7% | 2,509,468 | -28.9% | 0.24% | -46.5% |
| Q4 2019 | $5,331,000 | -7.8% | 3,530,731 | -9.7% | 0.44% | -50.9% |
| Q3 2019 | $5,784,000 | +20.8% | 3,908,265 | +5.3% | 0.89% | +36.5% |
| Q2 2019 | $4,788,000 | -16.7% | 3,711,454 | +68.6% | 0.66% | +25.0% |
| Q1 2019 | $5,746,000 | +58.2% | 2,201,697 | 0.0% | 0.52% | +28.1% |
| Q4 2018 | $3,633,000 | -9.9% | 2,201,697 | +164.7% | 0.41% | -11.7% |
| Q3 2018 | $4,034,000 | +83.3% | 831,697 | +136.2% | 0.46% | +52.8% |
| Q2 2018 | $2,201,000 | -17.3% | 352,142 | +9.8% | 0.30% | -25.0% |
| Q1 2018 | $2,662,000 | +53.5% | 320,692 | +88.6% | 0.40% | +99.0% |
| Q4 2017 | $1,734,000 | – | 170,032 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,858,889 | $7,337,000 | 5.11% |
| Proxima Capital Management, LLC | 170,294 | $257,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,530,731 | $5,331,000 | 0.44% |
| Nantahala Capital Management | 4,610,000 | $6,961,000 | 0.21% |
| Wealthstar Advisors, LLC | 73,295 | $111,000 | 0.07% |
| Alambic Investment Management, L.P. | 51,733 | $78,000 | 0.06% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $151,000 | 0.05% |
| BCS Wealth Management | 29,520 | $45,000 | 0.03% |
| Allred Capital Management, LLC | 24,995 | $37,742,000 | 0.02% |
| ALGERT GLOBAL LLC | 34,254 | $52,000 | 0.02% |